Search Results - "Solorzano, Jose L"

CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma by Rocha, Pedro, Salazar, Ruth, Zhang, Jiexin, Ledesma, Debora, Solorzano, Jose L., Mino, Barbara, Villalobos, Pamela, Dejima, Hitoshi, Douse, Dzifa Y., Diao, Lixia, Mitchell, Kyle Gregory, Le, Xiuning, Zhang, Jianjun, Weissferdt, Annikka, Parra-Cuentas, Edwin, Cascone, Tina, Rice, David C., Sepesi, Boris, Kalhor, Neda, Moran, Cesar, Vaporciyan, Ara, Heymach, John, Gibbons, Don L., Lee, J. Jack, Kadara, Humam, Wistuba, Ignacio, Behrens, Carmen, Solis, Luisa Maren

“…Introduction CD73 is a membrane-bound enzyme crucial in adenosine generation. The adenosinergic pathway plays a critical role in immunosuppression and in…”
Get full text

Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma by Rocha, Pedro, Salazar, Ruth, Zhang, Jiexin, Ledesma, Debora, Solorzano, Jose L., Mino, Barbara, Villalobos, Pamela, Dejima, Hitoshi, Douse, Dzifa Y., Diao, Lixia, Mitchell, Kyle Gregory, Le, Xiuning, Zhang, Jianjun, Weissferdt, Annikka, Parra-Cuentas, Edwin, Cascone, Tina, Rice, David C., Sepesi, Boris, Kalhor, Neda, Moran, Cesar, Vaporciyan, Ara, Heymach, John, Gibbons, Don L., Lee, J. Jack, Kadara, Humam, Wistuba, Ignacio, Behrens, Carmen, Solis, Luisa Maren

“…The original version of this article unfortunately contained a mistake…”
Get full text

JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells by Fernández, Sara, Solórzano, Jose L., Díaz, Eva, Menéndez, Victoria, Maestre, Lorena, Palacios, Sara, López, Mar, Colmenero, Argentina, Estévez, Mónica, Montalbán, Carlos, Martínez, Ángel, Roncador, Giovanna, García, Juan F.

“…•CSF3R is identified as a biomarker of JAK/STAT constitutive activation in Hodgkin and Reed-Sternberg cells.•JAK/STAT blockade activates the G2/M checkpoint…”
Get full text

Functional expression of CD137 (4-1BB) on T helper follicular cells by Alfaro, Carlos, Echeveste, Jose I, Rodriguez-Ruiz, Maria E, Solorzano, Jose L, Perez-Gracia, Jose L, Idoate, Miguel A, Lopez-Picazo, Jose M, Sanchez-Paulete, Alfonso R, Labiano, Sara, Rouzaut, Ana, Oñate, Carmen, Aznar, Angela, Lozano, Maria D, Melero, Ignacio

“…CD137 (4-1BB) is a surface protein initially discovered to mark activated T lymphocytes. However, its broader expression pattern also encompasses activated NK…”
Get full text

Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma by Menéndez, Victoria, Solórzano, José L., García-Cosío, Mónica, Cereceda, Laura, Díaz, Eva, Estévez, Mónica, Roncador, Giovanna, Vega, Zaira, Montalbán, Carlos, Kulasinghe, Arutha, García, Juan F.

“…As around 25% to 30% of classical Hodgkin lymphoma (cHL) patients with advanced stages do not respond to standard therapies, the tumor microenvironment of cHL…”
Get full text

Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma by Menéndez, Victoria, Solórzano, José L., García-Cosío, Mónica, Alonso-Alonso, Ruth, Rodríguez, Marta, Cereceda, Laura, Fernández, Sara, Díaz, Eva, Montalbán, Carlos, Estévez, Mónica, Piris, Miguel A., García, Juan F.

“…Classic Hodgkin lymphoma (cHL) is characterized by a rich immune microenvironment as the main tumor component. It involves a broad range of cell populations,…”
Get full text

Author Correction: Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma by Menéndez, Victoria, Solórzano, José L., García-Cosío, Mónica, Alonso-Alonso, Ruth, Rodríguez, Marta, Cereceda, Laura, Fernández, Sara, Díaz, Eva, Montalbán, Carlos, Estévez, Mónica, Piris, Miguel A., García, Juan F.

Get full text

Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma by Solórzano, José L, Menéndez, Victoria, Parra, Edwin, Solis, Luisa, Salazar, Ruth, García-Cosío, Mónica, Climent, Fina, Fernández, Sara, Díaz, Eva, Francisco-Cruz, Alejandro, Khoury, Joseph, Jiang, Mei, Tamegnon, Auriole, Montalbán, Carlos, Melero, Ignacio, Wistuba, Ignacio, De Andrea, Carlos, F García, Juan

“…The Hodgkin and Reed - Sternberg (HRS) cells in classical Hodgkin Lymphoma (cHL) actively modify the immune tumor microenvironment (TME) attracting…”
Get full text

The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good by Menéndez, Victoria, Solórzano, José L, Fernández, Sara, Montalbán, Carlos, García, Juan F

“…The classic Hodgkin lymphoma (cHL) tumor microenvironment (TME) is by far the most abundant component of tumors and is responsible for most of their biological…”
Get full text

Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG‐PET/CT by Fernández, Sara, Cereceda, Laura, Díaz, Eva, Figueroa, Sasha, Reguera, Laura, Menéndez, Victoria, Solórzano, José L., Montalbán, Carlos, Estévez, Mónica, García, Juan F.

“…The value of circulating tumor DNA (ctDNA) as a biomarker of disease activity in classic Hodgkin lymphoma (cHL) patients has not yet been well established. By…”
Get full text

Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma by Hernández-Argüello, Miguel, Quiceno, Hernán, Pascual, Ignacio, Solorzano, José L, Benito, Alberto, Collantes, María, Rodríguez-Fraile, Macarena, Pardo, Javier, Richter, José A

“…Index lesion characterization is important in the evaluation of primary prostate carcinoma (PPC). The aim of this study was to analyze the contribution of (11)…”
Get full text

Index lesion characterization by 11C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma by Hernández-Argüello, Miguel, Quiceno, Hernán, Pascual, Ignacio, Solorzano, José L., Benito, Alberto, Collantes, María, Rodríguez-Fraile, Macarena, Pardo, Javier, Richter, José A.

“…BACKGROUND Index lesion characterization is important in the evaluation of primary prostate carcinoma (PPC). The aim of this study was to analyze the…”
Get full text

Abstract 1124: PTEN loss confers resistance to anti-PD-1 therapy in NSCLC by increasing tumor infiltration of T regulatory cells by Exposito, Francisco, Redrado, Miriam, Houry, Maeva, Hastings, Katherine, Molero-Abraham, Magdalena, Lozano, Teresa, Solorzano, Jose L., Ortega, Julian Sanz, Andradas, Vera, Amat, Ramon, Redin, Esther, Leon, Sergio, Legarra, Naroa, García, Javier, Serrano, Diego, Valencia, Karmele, Robles-Oteiza, Camila, Foggetti, Giorgia, Felip, Enriqueta, Lasarte, Juan J., Paz-Ares, Luis, Zugazagoitia, Jon, Politi, Katerina, Montuenga, Luis M, Calvo, Alfonso

“…Immune checkpoint inhibitors (ICIs) targeting PD-L1/PD-1 have dramatically improved the management of NSCLC patients. Nevertheless, more than 50% patients will…”
Get full text

Index lesion characterization by 11 C‐Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma by Hernández‐Argüello, Miguel, Quiceno, Hernán, Pascual, Ignacio, Solorzano, José L., Benito, Alberto, Collantes, María, Rodríguez‐Fraile, Macarena, Pardo, Javier, Richter, José A.

Get full text